FDA 510(k)

Alere i Influenza A & B, Alere i Influenza A & B Control Swab Kit, Alere i Instrument

K-Nummer: K163266 · 2016-12-21

Entscheidungsdatum2016-12-21

ProduktcodeOCC

BeratungsausschussMI

EntscheidungSubstantially Equivalent

Produktübersicht

Alere i Influenza A & B, Alere i Influenza A & B Control Swab Kit, Alere i Instrument is the device name listed in this FDA 510(k) record. The listed applicant is Alere Scarborough, Inc.. It received FDA 510(k) clearance on 2016-12-21 under 510(k) number K163266. The device is classified under product code OCC. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Häufig gestellte Fragen

What is the Alere i Influenza A & B, Alere i Influenza A & B Control Swab Kit, Alere i Instrument?

Alere i Influenza A & B, Alere i Influenza A & B Control Swab Kit, Alere i Instrument is a medical device that received FDA 510(k) clearance on 2016-12-21. The listed applicant is Alere Scarborough, Inc.. The 510(k) number is K163266.

When did Alere i Influenza A & B, Alere i Influenza A & B Control Swab Kit, Alere i Instrument receive FDA 510(k) clearance?

Alere i Influenza A & B, Alere i Influenza A & B Control Swab Kit, Alere i Instrument received FDA 510(k) clearance on 2016-12-21, under 510(k) number K163266.

Who is the listed applicant for Alere i Influenza A & B, Alere i Influenza A & B Control Swab Kit, Alere i Instrument?

The FDA 510(k) record lists Alere Scarborough, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Alere i Influenza A & B, Alere i Influenza A & B Control Swab Kit, Alere i Instrument?

The FDA product code for Alere i Influenza A & B, Alere i Influenza A & B Control Swab Kit, Alere i Instrument is OCC.

Zugehörige klinische Studien

Zugehörige Einträge werden automatisch anhand von Namen, Produktcodes oder anderen Metadaten abgeglichen. Eine Übereinstimmung begründet kein verifiziertes klinisches, wissenschaftliches, unternehmerisches oder regulatorisches Verhältnis; prüfen Sie die verlinkten offiziellen Quellen.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITING NCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITING NCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDED NCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Weitere Einträge mit Alere Scarborough, Inc. als Antragsteller

K190204ID NOW Influenza A & B 2 K181853Alere BinaxNOW Influenza A & B Karte 2, Alere Reader K173653Alere i Strep A 2, Alere i Gerät, Alere i Strep A 2 Kontrollswabentestkit K173932Alere i Influenza A & B, Alere i Strep A, Alere i RSV, Alere i Influenza A & B 2 K173502Alere BinaxNOW Influenza A & B Karte 2, Alere Reader, Alere BinaxNOW Influenza A & B Karte 2 Kontrollswabsatz K171792Alere i Influenza A & B 2, Alere i Instrument, Alere i Influenza A & B Control Swab Kit

Alle 10 Geräte anzeigen →

Verwandte Geräte (Code: OCC)

K262747ID NOW Influenza A & B 2; ID NOW RSV; ID NOW Strep A 2; ID NOW COVID-19 2.0Abbott Diagnostics Scarborough, Inc.K254139BioCode® Respiratory Pathogen Panel (RPP)Applied BioCode, Inc.K242613NxTAG® Respiratory Pathogen PanelLuminex Molecular Diagnostics, Inc.K232775ID NOW Influenza A & B 2Abbott Diagnostics Scarborough, Inc.K231017Panther Fusion AdV/hMPV/RV AssayHologic, Inc.K213822cobas Influenza A/B & RSV nucleic acid test for use on the cobas Liat SystemRoche Molecular Systems, Inc.

Offizielle Quelle

In der FDA-Datenbank anzeigen →

Daten aus der FDA Open API. Für die aktuellsten und verbindlichen Informationen konsultieren Sie bitte stets den offiziellen Datensatz.